An interventional study of Cognitive-behavioral group therapy in Kidney Failure, Chronic, Depression and Quality of Life, sponsored by Seoul National University Boramae Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2015-11-20.
Sponsored by Seoul National University Boramae Hospital · Not applicable, Interventional, and Supportive care
Depression is common in end-stage renal disease (ESRD) patients and has a negative effect on the quality of life, functional ability, and mortality, with a prevalence rate as high as 20-25%. However, it is hard to use anti-depressant due to the safety issue, and there has been little data so far particularly in terms of randomized clinical trials. Here, we investigate the effect of cognitive-behavioral group therapy for enhancing mental health and quality of life in patients with ESRD.
1,995 studies on the registry are indexed under Renal Insufficiency; 173 are open to participants now.
This study's enrollment of 15 is below the median of 43 across 1,504 interventional studies indexed under Renal Insufficiency.
Browse Renal Insufficiency studies →Seoul National University Boramae Hospital is the lead sponsor of 12 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
12 sessions of Cognitive-behavioral group therapy in the first 12 weeks
Behavioral: Cognitive-behavioral group therapy
12 sessions of Cognitive-behavioral group therapy in the second 12 weeks
Behavioral: Cognitive-behavioral group therapy
Beck Depression Inventory-II (BDI-II) score
Time frame: 3 months
Secondary assessment tools for depression,anxiety, and quality of life
Hamilton Depression Rating Scale (HAMD-17): assessment for depressive mood
Time frame: 3 months
Secondary assessment tools for depression,anxiety, and quality of life
Beck Anxiety Inventory (BAI)
Time frame: 3 months
Secondary assessment tools for depression,anxiety, and quality of life
The Perceived Stress Scale
Time frame: 3 months
Secondary assessment tools for depression,anxiety, and quality of life
KD-QOL: quality of life related with kidney disease
Time frame: 3 months
Secondary assessment tools for depression,anxiety, and quality of life
WHOQOL_BREF: overall quality of life
Time frame: 3 months
Secondary assessment tools for depression,anxiety, and quality of life
Temperament and Character Inventory (TCI)
Time frame: 3 months
Secondary assessment tools for depression,anxiety, and quality of life
Diagnosis of major depressive disorder by DSM-IV
Time frame: 3 months
Secondary assessment tools for depression,anxiety, and quality of life
Biomarker related with depression: serotonin level and etc.
Time frame: 3 months
Secondary assessment tools for depression,anxiety, and quality of life
Additional anti-depressant use after trial
Time frame: 3 months
This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Boramae Hospital